Silence Therapeutics plc (SLN) stock, explained like you're 5

Is Silence Therapeutics plc a small, medium or large cap company?

No. Silence Therapeutics plc is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 613 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Silence Therapeutics plc makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves SLN stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Silence Therapeutics (SLN) Loses 28.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Yahoo Finance Singapore)
• Call options cover 1.5M shares in an amended stake report for Silence Therapeutics (SLN). (Stock Titan)
• Silence Therapeutics stock surges as divesiran trial results fuel optimism (SLN:NASDAQ) (Seeking Alpha)
• Silence Therapeutics (SLN) Upgraded to Buy: Here's Why (Yahoo! Finance Canada)
• Understanding Momentum Shifts in (SLN) (Stock Traders Daily)

Key terms to know before you follow SLN

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility